CAPRICOR THERAPEUTICS, INC.
- May 19, 2017 · D · $3,708,503 sold of $3,708,503 · 4 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- Mar 29, 2016 · D · $13,974 sold of $13,974 · 24 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- Feb 19, 2015 · D · $7,050,001 sold of $7,050,001 · 8 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- Feb 3, 2015 · D · $10,002,028 sold of $10,002,028 · 39 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- Feb 24, 2014 · D · $32,676 sold of $32,676 · 1 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- Dec 5, 2013 · D · $26,289,973 sold of $26,289,973 · 34 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
Raised $26.3M from 39 investors (100% of the $3.71M target) as of the latest filing. Anthony is listed as executive officer on 6 filings for this deal.
Sources
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.